Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:16 pm Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | VANGUARD GROUP INC | 3,456,087 6.010% | -536,079 (-13.43%) | View |
| 2024-02-13 10:53 am Purchase | 13G | Vanda Pharmaceuticals Inc. VNDA | RENAISSANCE TECHNOLOGIES LLC | 3,681,125 6.400% | 791,700 (+27.40%) | View |
| 2024-02-09 09:59 am Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | DIMENSIONAL FUND ADVISORS LP | 1,967,985 3.400% | -885,847 (-31.04%) | View |
| 2024-01-23 11:52 am Purchase | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 8,346,367 14.500% | 1,587,250 (+23.48%) | View |
| 2024-01-22 11:26 am Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | STATE STREET CORP STT | 1,228,096 2.130% | -2,499,702 (-67.06%) | View |
| 2023-10-06 2:34 pm Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 6,759,117 11.800% | -3,567,497 (-34.55%) | View |
| 2023-02-14 4:23 pm Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | Palo Alto Investors LP | 1,087,064 1.420% | -1,747,180 (-61.65%) | View |
| 2023-02-14 1:34 pm Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | MACQUARIE GROUP LTD | 1,323,547 2.340% | -1,589,924 (-54.57%) | View |
| 2023-02-13 11:33 am Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | RENAISSANCE TECHNOLOGIES LLC | 2,889,425 5.090% | -322,789 (-10.05%) | View |
| 2023-02-10 2:42 pm Purchase | 13G | Vanda Pharmaceuticals Inc. VNDA | DIMENSIONAL FUND ADVISORS LP | 2,853,832 5.000% | 2,853,832 (New Position) | View |
| 2023-02-09 11:35 am Purchase | 13G | Vanda Pharmaceuticals Inc. VNDA | VANGUARD GROUP INC | 3,992,166 7.050% | 115,482 (+2.98%) | View |
| 2023-02-07 2:24 pm Purchase | 13G | Vanda Pharmaceuticals Inc. VNDA | STATE STREET CORP STT | 3,727,798 6.590% | 400,365 (+12.03%) | View |
| 2023-01-24 1:56 pm Purchase | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 10,326,614 18.200% | 501,239 (+5.10%) | View |
| 2022-02-14 9:56 pm Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | ARMISTICE CAPITAL LLC | 0 0.000% | -5,399,277 (Position Closed) | View |
| 2022-02-14 5:08 pm Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | Palo Alto Investors LP | 2,834,244 5.090% | -1,396,304 (-33.01%) | View |
| 2022-02-14 11:15 am Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | MACQUARIE GROUP LTD | 2,913,471 5.230% | -278,563 (-8.73%) | View |
| 2022-02-11 9:12 pm Purchase | 13G | Vanda Pharmaceuticals Inc. VNDA | STATE STREET CORP STT | 3,327,433 5.970% | 123,529 (+3.86%) | View |
| 2022-02-11 3:57 pm Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | RENAISSANCE TECHNOLOGIES LLC | 3,212,214 5.770% | -778,189 (-19.50%) | View |
| 2022-02-10 08:42 am Sale | 13G | Vanda Pharmaceuticals Inc. VNDA | VANGUARD GROUP INC | 3,876,684 6.960% | -82,396 (-2.08%) | View |
| 2022-01-27 5:14 pm Unchanged | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 9,825,375 17.600% | 0 (Unchanged) | View |